Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (309) Arrow Down
Filter Results: (309) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (398)
    • News  (48)
    • Research  (309)
    • Multimedia  (1)
  • Faculty Publications  (248)

Show Results For

  • All HBS Web  (398)
    • News  (48)
    • Research  (309)
    • Multimedia  (1)
  • Faculty Publications  (248)
← Page 3 of 309 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • November 2012
  • Supplement

Amylin Pharmaceuticals (B)

By: Richard G. Hamermesh and Carin-Isabel Knoop
Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the company remained unprofitable as sales plateaued. The small pharmaceutical... View Details
Keywords: Pharmaceuticals; Bristol-Myers Squibb; Health Care and Treatment; Pharmaceutical Industry; United States
Citation
Purchase
Related
Hamermesh, Richard G., and Carin-Isabel Knoop. "Amylin Pharmaceuticals (B)." Harvard Business School Supplement 813-091, November 2012.
  • November 2008 (Revised January 2010)
  • Case

Stone Finch, Inc.: Young Division, Old Division

By: Richard G. Hamermesh and Elizabeth Collins
CEO Jim Billings wants to attract energetic, entrepreneurial talent to Stone Finch, Inc., which comprises an older division that fabricates products like piping and tanks for water and wastewater processing plants, and a much newer division that develops biochemical... View Details
Keywords: Organizational Behavior; Human Resource Management; Motivation; Business Growth; Motivation and Incentives; Leadership; Business Subsidiaries; Innovation Strategy; Resource Allocation; Organizational Structure; Organizational Culture; Retention; Operations; Recruitment; Integration; Business Growth and Maturation; Mergers and Acquisitions; Growth and Development Strategy; Manufacturing Industry
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and Elizabeth Collins. "Stone Finch, Inc.: Young Division, Old Division." Harvard Business School Brief Case 083-214, November 2008. (Revised January 2010.)
  • December 1998 (Revised June 1999)
  • Case

STT Aerospace

By: Richard G. Hamermesh and Jeremy Dann
Experienced entrepreneur Charles Damon conducted a "roll-up" from 1987-1994 within the commercial airliner interior products industry. Damon's company, STT Aerospace, took advantage of an industry-wide recession in the early 1990s by buying when asset prices were low.... View Details
Keywords: Retention; Business Strategy; Selection and Staffing; Entrepreneurship; Financial Crisis; Growth and Development Strategy; Compensation and Benefits; Employee Stock Ownership Plan; Acquisition; Product Development; Aerospace Industry
Citation
Find at Harvard
Related
Hamermesh, Richard G., and Jeremy Dann. "STT Aerospace." Harvard Business School Case 399-056, December 1998. (Revised June 1999.)
  • June 2001 (Revised November 2004)
  • Case

Kingsley Management

By: Richard G. Hamermesh
Includes a brief overview of key challenges facing recent HBS graduates seeking funding for a business, followed by a 22-page excerpt from the Kingsley Management business plan. Describes Matthew Lieb and Chris Jones, two of the partners who developed the business plan... View Details
Keywords: Business Organization; Corporate Entrepreneurship; Business Plan; Opportunities; Investment Return; Organizational Structure
Citation
Educators
Purchase
Related
Hamermesh, Richard G. "Kingsley Management." Harvard Business School Case 801-474, June 2001. (Revised November 2004.)
  • January 2007 (Revised January 2007)
  • Background Note

Note on the U.S. Food and Drug Administration

By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Medical Devices and Supplies Industry; Biotechnology Industry; Public Administration Industry; United States
Citation
Educators
Purchase
Related
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
  • Article

One Obstacle to Curing Cancer: Patient Data Isn't Shared

By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For... View Details
Keywords: Healthcare; Technological And Scientific Innovation; Cancer Care In The U.S.; Cancer Treatment; Precision Medicine; Personalized Medicine; Data Sharing; Technological Innovation; Analytics and Data Science; Health Disorders; Medical Specialties; Research and Development; Customization and Personalization; Health Industry; United States
Citation
Register to Read
Related
Hamermesh, Richard G., and Kathy Giusti. "One Obstacle to Curing Cancer: Patient Data Isn't Shared." Harvard Business Review (website) (November 28, 2016).
  • January 2014
  • Teaching Plan

MedImmune Ventures

By: Richard Hamermesh and Andrew Otazo
"MedImmune Ventures" highlights the problems faced by corporate venture capital firms, the challenges of investing in early-stage healthcare, and the difficulty of operating in distant markets. View Details
Keywords: MedImmune Ventures; NeuProtect; Corporate Venture Capital; Ron Laufer; Australia; Starfish Ventures; AstraZeneca; MEVE; Healthcare; Startup; Venture Capital; Business Startups; Health Industry; Australia; United States
Citation
Purchase
Related
Hamermesh, Richard, and Andrew Otazo. "MedImmune Ventures." Harvard Business School Teaching Plan 814-039, January 2014.
  • May 2012
  • Case

Westlake Lanes: How Can This Business Be Saved?

By: Richard G. Hamermesh and Alisa Zalosh
Shelby Givens, a new MBA, is the general manager of Westlake Lanes, a near-bankrupt bowling alley that her grandfather founded decades earlier. Givens has been given one year to turn a profit; if the goal is not met Westlake will close. During the first few days on the... View Details
Keywords: United States; Operations Management; Small And Medium-sized Enterprises; Turnarounds; Strategy; Leading Change; Marketing Strategy; Entrepreneurship; Operations; Transformation; Growth and Development Strategy; Entertainment and Recreation Industry; United States
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and Alisa Zalosh. "Westlake Lanes: How Can This Business Be Saved?" Harvard Business School Brief Case 124-431, May 2012.
  • March 2010 (Revised June 2010)
  • Case

Whose Money Is It Anyway? (A)

By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The Brigham and Women's Physician's Organization (BWPO) and its corporate parent disagree over who has jurisdiction over significant legacy funds. Are they controlled by the BWPO or do they belong to BWPO's corporate parent? The BWPO and its corporate parent must... View Details
Keywords: Accounting; Investment Funds; Governance Controls; Agreements and Arrangements; Boundaries; Health Industry
Citation
Educators
Purchase
Related
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "Whose Money Is It Anyway? (A)." Harvard Business School Case 810-008, March 2010. (Revised June 2010.)
  • 10 Nov 2009
  • First Look

First Look: Nov. 10

revolutionary functionality. We explore a second path to entry that does not rely on Schumpeterian innovation: platform envelopment. By leveraging shared user relationships and common components, one platform provider can move into... View Details
Keywords: Martha Lagace
  • 25 Sep 2012
  • First Look

First Look: September 25

rate. Latvia's policy program and initial results are discussed in the case. Purchase this case:http://hbr.org/search/711053-PDF-ENG Lyric Dinner Theater (A) Richard G. View Details
Keywords: Sean Silverthorne
  • November 2016 (Revised November 2016)
  • Case

Radial Analytics Probes Post-Acute Care

By: Richard G. Hamermesh and Olivia Hull
Thaddeus Fulford-Jones and Eric Weiss, founders of healthcare technology startup Radial Analytics, have been busy developing a software program designed to save hospitals money and improve patient outcomes by producing customized care plans for patients leaving the... View Details
Keywords: Electronic Medical Records; Electronic Health Records; Data Science; Entrepreneurship; Health Care and Treatment; Business Model; Business Startups; Innovation and Invention; Growth Management; Marketing Strategy; Product Launch; Product Positioning; Science-Based Business; Business Strategy; Health Industry; Technology Industry; Cambridge; Massachusetts
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and Olivia Hull. "Radial Analytics Probes Post-Acute Care." Harvard Business School Case 817-029, November 2016. (Revised November 2016.)
  • December 2005 (Revised May 2007)
  • Case

Cynthia Fisher and the Rearing of ViaCell

By: Robert F. Higgins, Richard G. Hamermesh and Ingrid Vargas
Describes the start up of Viacord, a Boston-based medical services firm founded by Cynthia Fisher (HBS MBA) in 1993. Told from Fisher's perspective, the entrepreneur details the conceptualization and launch of the business and the many obstacles and expenses faced in... View Details
Keywords: Managerial Roles; Business Growth and Maturation; Entrepreneurship; Business Startups; Service Industry; Health Industry; Boston
Citation
Educators
Purchase
Related
Higgins, Robert F., Richard G. Hamermesh, and Ingrid Vargas. "Cynthia Fisher and the Rearing of ViaCell." Harvard Business School Case 806-002, December 2005. (Revised May 2007.)
  • 04 May 2010
  • First Look

First Look: May 4

Biomedical: Making Pigs Fly Richard G. Hamermesh, Lauren Barley, and Ginger L. GrahamHarvard Business School Case 809-051 Proteus is a healthcare start-up that has developed technology to embed electronics... View Details
Keywords: Martha Lagace
  • October 2013 (Revised January 2014)
  • Supplement

Fred Khosravi and AccessClosure (B)

By: Richard G. Hamermesh and Lauren Barley
It was January 2013, and Fred Khosravi, chairman of the board of AccessClosure Inc., wondered what the new year had in store for him and AccessClosure, the company he founded in late 2002. Khosravi was cautiously optimistic—the Mountain View, California-based medical... View Details
Keywords: Medical Devices; Vascular Closure Device; Patent Litigation; Patenting; Biomedical Research; Biotechnology; Biotech; Technological Innovation; Patents; Health Care and Treatment; Biotechnology Industry; United States; California
Citation
Purchase
Related
Hamermesh, Richard G., and Lauren Barley. "Fred Khosravi and AccessClosure (B)." Harvard Business School Supplement 814-038, October 2013. (Revised January 2014.)
  • 27 Sep 2011
  • First Look

First Look: September 27

Intervention Method, Empirical Evidence, and Theory Author:Michael Beer Publication:In Research in Organizational Change and Development. Vol. 19, edited by Richard Woodman, William Pasmore, and Abraham B.... View Details
Keywords: Sean Silverthorne
  • February 2015 (Revised November 2015)
  • Case

Building an Integrated Biopharma Company: Crucell (A)

By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing; Licensing Agreements In Biopharmacy; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Partners and Partnerships; Entrepreneurship; Growth and Development Strategy; Biotechnology Industry; Pharmaceutical Industry; Netherlands
Citation
Educators
Purchase
Related
Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)
  • 1982
  • Book

Business Policy: Text and Cases

By: C. Roland Christensen, Kenneth R. Andrews, Joseph L. Bower, Richard G. Hamermesh and Michael E. Porter
Keywords: Policy; Information; Cases
Citation
Find at Harvard
Related
Christensen, C. Roland, Kenneth R. Andrews, Joseph L. Bower, Richard G. Hamermesh, and Michael E. Porter. Business Policy: Text and Cases. 5th ed. Homewood, IL: Richard D. Irwin, 1982.
  • 01 Feb 2011
  • First Look

First Look: Feb. 1

Medical Richard G. Hamermesh and Lauren BarleyHarvard Business School Case 810-027 Novasys has developed a new medical device and procedure for the treatment of female stress... View Details
  • December 2022
  • Article

Collaborative Rooming: An Innovative Pilot Project to Overcome Primary Care Challenges

By: Gagandeep Singh, Jill G. Lenhart, Richard A. Helmers, Michele Renee Eberlee, Heather Costley, Joel B. Roberts and Robert S. Kaplan
Primary care physicians are overburdened with growing complexities and increasing expectations for primary care visits. To meet expectations, primary care physicians must multitask during visits and spend extra hours in the office for charting, billing, and... View Details
Keywords: Health Care and Treatment; Groups and Teams; Job Design and Levels; Health Industry
Citation
Read Now
Related
Singh, Gagandeep, Jill G. Lenhart, Richard A. Helmers, Michele Renee Eberlee, Heather Costley, Joel B. Roberts, and Robert S. Kaplan. "Collaborative Rooming: An Innovative Pilot Project to Overcome Primary Care Challenges." Wisconsin Medical Journal 121, no. 4 (December 2022): 306–309.
  • ←
  • 3
  • 4
  • …
  • 15
  • 16
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.